News & Blog

Tag Archives: Patient life

International Low-Grade Glioma Patient Registry

Low-grade gliomas (LGG), those classified as Grade II by the World Health Organization, are an understudied group of brain tumors that generally strikes patients in the prime of life. They have a lower average age at diagnosis, but fortunately have a better survival prognosis than high-grade gliomas (those classified as Grades III and IV). While […]

Brain Tumor Research Highlights: November 2016

NOTE: In October, our 2016 NBTS Scientific Summit Recap replaced our typical monthly Brain Tumor Research Highlights. To view that post, click here. To view September’s Brain Tumor Research Highlights, see here. Over the years, NBTS has given more than $32 million to brain tumor research projects. We’re very proud of the impact this funding […]

Survey Results: Clinical Trial Participation

  National Brain Tumor Society, in conjunction with neuro-oncologists, scientific researchers, and the biopharmaceutical industry, is constantly looking for new and better treatments for patients. However, scientific progress in a laboratory does not necessarily always lead to new treatments for patients. First, those laboratory results need to be evaluated and confirmed in high quality clinical trials to ensure […]

Share